Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse eventsHeinz Läubli, Sacha I. Rothschild|Journal for ImmunoTherapy of Cancer|2018Cited by 131
Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver AlterationsDavid König, Sacha I. Rothschild|Cancers|2021Cited by 112
557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trialPatrizia Froesch, Martin Früh, Sacha I. Rothschild et al.|Annals of Oncology|2020Cited by 1